HongKong:2235

Qiming's Portfolio Company Microtech Medical Lists on Main Board of HKEx

SHANGHAI, Oct. 19, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Microtech Medical (SEHK:2235), a leading Chinese diabetes management medical device maker, today listed on the main board of the Hong Kong Stock Exchange. The issue price isHK$ 30.5 per share. The stock opened a...

2021-10-19 14:07 3589

Week's Top Stories

Most Reposted

Multiple achievements made in China-Hungary BRI conference

[Picked up by 319 media titles]

2024-05-03 06:59
Multiple achievements made in China-Hungary BRI conference

Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity

[Picked up by 318 media titles]

2024-05-07 08:00
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity

VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation

[Picked up by 318 media titles]

2024-05-08 14:37
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation

OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology

[Picked up by 310 media titles]

2024-05-08 08:00

IN2MF in Kuala Lumpur Presented by Bank Indonesia

[Picked up by 296 media titles]

2024-05-08 16:44
IN2MF in Kuala Lumpur Presented by Bank Indonesia

Most Read

/C O R R E C T I O N -- Addverb/

2024-05-03 20:26 15028
/C O R R E C T I O N -- Addverb/

Multiple achievements made in China-Hungary BRI conference

2024-05-03 06:59 10441
Multiple achievements made in China-Hungary BRI conference

Xinhua president, Hungarian economy minister vow to bolster media cooperation

2024-05-03 06:25 9816

Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement

2024-05-03 14:47 6631
Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement

Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent or Metastatic Solid Tumors in Late-breaking Oral Presentation at the 2024 ASCO Annual Meeting

2024-05-08 18:18 5102